This is a routine investor presentation filing with no new material information. Monitor for future filings containing clinical updates, financial results, or financing activities for trading catalysts.
Price Chart
Executive Summary
NRX Pharmaceuticals filed an 8-K furnishing an investor presentation used in meetings with investors and analysts on September 8, 2026. The filing is a routine Regulation FD disclosure with no new material financial data, guidance, or corporate events. The presentation content was not extractable from the provided documents, limiting analysis to the filing's procedural nature.
Key Facts
- NRX Pharmaceuticals filed an 8-K on September 14, 2026, regarding Item 7.01 Regulation FD Disclosure.
- The filing furnishes an investor presentation (Exhibit 99.1) used in meetings on September 8, 2026.
- No financial results, guidance, or material corporate events were disclosed in the 8-K body.
- The investor presentation content was not available for analysis.
Financial Impact
Not specified
Risk Factors
- No material financial or operational data disclosed; stock movement may be driven by unstated market expectations.
- Investor presentation content was unavailable, limiting insight into management's messaging.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-030228 |
| Document: 0001437749-26-030228-index-headers.html | 0001437749-26-030228 |
| Document: 0001437749-26-030228-index.html | 0001437749-26-030228 |
| Document: 0001437749-26-030228.txt | 0001437749-26-030228 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $3.35 $3.16 | ▼ −5.67% | ▼ −8.24% | $2.90 (−13.28%) |
Sep 14, 2026 18d ago | 8-K | $3.49 $3.29 | ▼ −5.73% | ▼ −5.84% | $2.90 (−16.76%) |
Aug 17, 2026 6w ago | 8-K | $3.43 $3.45 | ▲ +0.58% | ▲ +1.77% | $2.90 (−15.31%) |
Aug 17, 2026 6w ago | Press Release | $3.43 $3.45 | ▲ +0.58% | ▲ +1.77% | $2.90 (−15.31%) |
Aug 7, 2026 8w ago | 8-K | $3.58 $3.27 | ▼ −8.66% | ▼ −9.06% | $2.90 (−18.85%) |
Jul 22, 2026 10w ago | 8-K | $4.48 $3.23 | ▼ −27.90% | ▼ −25.50% | $2.90 (−35.16%) |
Jun 22, 2026 14w ago | Press Release | $3.90 $3.73 | ▼ −4.36% | ▼ −2.29% | $2.90 (−25.51%) |
Jun 5, 2026 17w ago | Press Release | $4.14 $3.84 | ▼ −7.25% | ▼ −7.82% | $2.90 (−29.83%) |
Jun 4, 2026 17w ago | Press Release | $4.14 $3.84 | ▲ +7.25% | ▲ +7.82% | $2.90 (+29.83%) |
Jun 3, 2026 17w ago | Press Release | $4.05 $3.76 | ▲ +7.16% | ▲ +3.34% | $2.90 (+28.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access